Mineralys Therapeutics (MLYS) Accounts Payables (2022 - 2026)
Mineralys Therapeutics' Accounts Payables was $1.07 million in Q2 2026, down 66.3% from $3.16 million a year earlier and down 4.5% from the prior quarter.
Powered by 
Analysis
Mineralys Therapeutics (MLYS) Accounts Payables (2022 - 2026) Analysis & Trends
At the end of FY2025, Accounts Payables at Mineralys Therapeutics came in at $2.02 million, up 321.1% from FY2024.
- Accounts Payables shows a three-year compound annual growth rate of 1.9% (FY2022 to FY2025).
- In earlier years, Accounts Payables was $479,000 in FY2024 (-20.3%), $601,000 in FY2023 (-68.5%) and $1.91 million in FY2022.
- The Q2 2026 figure marks the lowest quarterly Accounts Payables since Q1 2025.
- Compared with a year earlier, Accounts Payables was higher in three of the last eight quarters, with growth averaging 40.0%.
- The best year-over-year quarter for Accounts Payables over five years was Q4 2025 (growth of 321.1%); the worst was Q1 2025 (a decline of 91.2%).
- Per Business Quant data, MLYS's Accounts Payables in the three quarters before Q2 2026 was $1.12 million (Q1 2026), $2.02 million (Q4 2025) and $1.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Mineralys Therapeutics | 2.22 Bn | 2.22 Bn | - | 1.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Mn |
| Mar 31, 2026 | 1.12 Mn |
| Dec 31, 2025 | 2.02 Mn |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 3.16 Mn |
| Mar 31, 2025 | 373,000.00 |
| Dec 31, 2024 | 479,000.00 |
| Sep 30, 2024 | 3.11 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 4.26 Mn |
| Dec 31, 2023 | 601,000.00 |
| Sep 30, 2023 | 5.57 Mn |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 2.39 Mn |
| Dec 31, 2022 | 1.91 Mn |
API Access
Mineralys Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=MLYS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "MLYS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=MLYS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();